Anti-MUC-1 monoclonal antibodyAlternative Names: Anti-MUC1 monoclonal antibody; HmAb16; Human anti-MUC-1 antibody; Human monoclonal antibody 16; MUC1 monoclonal antibody
Latest Information Update: 04 Apr 2003
$50 / €47 *
At a glance
- Originator Unknown
- Developer Dyax Corp.
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer; Ovarian cancer
Most Recent Events
- 04 Apr 2003 No development reported - Preclinical for Breast cancer in USA (unspecified route)
- 04 Apr 2003 No development reported - Preclinical for Ovarian cancer in USA (unspecified route)
- 18 Jul 2001 Preclinical development for Breast cancer in USA (Unknown route)